QGN-26576-81231
4 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 232 / VA
- Registered
- 2022-06-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
4BX-12208-38624
Child or adolescent in my care · Male · 2022-06-29
Timeline
-
2021-03-24
Dose 1 — Pfizer-BioNTech
-
2021-04-16
Dose 2 — Pfizer-BioNTech
-
2021-10-13
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-06-29
Registered in v-safe
-
2022-09-30
Dose 4 — ModernaCo-administered: Flu
-
2022-09-30
Health check-in — day 0, dose 4Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-01
Survey response — days 1–6 daily, dose 4MedDRA: Insomnia — Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Unable to sleepMedDRA releases: 2024-11 · check-in free text available
- 2022-10-02
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-06
- 2022-10-07
- 2022-10-14
- 2022-10-28
- 2022-11-06
- 2022-11-11
- 2022-12-31
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | No |
| 2 | 2021-04-16 | Pfizer-BioNTech | No |
| 3 | 2021-10-13 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-30 | Moderna | Flu |
Free text
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Unable to sleep
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Insomnia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release